Enter your login e-mail to the account
Search
- Immunotherapy in the treatment of urological malignancies
MUDr. Jana Katolická, Ph.D., MUDr. Petr Filipenský, Ph.D.
(3/2019, Review articles ) - Role of genetic testing at the deciding about the treatment of the kidney tumors
MUDr. Robert Novák, MUDr. Jana Katolická, Ph.D.
(1/2025, From the frontier of urology ) - Individualization of systemic treatment for advanced prostate cancer
MUDr. Jana Katolická, Ph.D., MUDr. Lucia Tomková
(2/2026, From the frontier of urology ) - Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology )
- Recent achievements in targeted treatment of advanced non-small cell lung cancer with rare RET, MET, BRAF and NTRK gene alterations
MUDr. Róbert Godál
(1/2021, Main topic ) - Primary myelofibrosis – current view of pathophysiology, prognosis and treatment
Prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2018, Spectrum ) - Current treatment options for BRAF mutant metastatic colorectal cancer
MUDr. Radovan Barila, PhD., MUDr. Igor Andrašina, CSc.
(1/2022, Main topic ) - The basics of management of certain adverse events of immune checkpoint inhibitors
Doc. JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2025, Review articles ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - News in the immunotherapy of nonmetastatic non-small-cell lung cancer
MUDr. Lenka Medvecová
(1/2023, Main topic ) - The theoretical basis of the synergy of radiotherapy and therapy using immune checkpoint inhibitors
Doc. MUDr. Milan Vošmik, Ph.D., MUC. Barbora Vošmiková
(1/2023, Main topic ) - Prophylaxis and treatment of lymphomatous central nervous system infiltration
MUDr. Alexander Wild, MUDr. Juliana Holasová
(3/2019, Main topic ) - Zaujímavosti zo zahraničnej literatúry
doc. MUDr. Peter Beržinec, CSc.
(3/2019, Information & comments ) - Treatment of patients with metastatic renal cancer after treatment with tyrosine kinase inhibitors
MUDr. Mária Rečková, PhD.
(4/2019, Review articles ) - Novinky z ASCO 2023, 15. ročník
MUDr. Mária Rečková, PhD.
(4/2023, Events ) - Current possibilities and view of treatment of castration refractory metastatic prostate cancer
MUDr. Radovan Barilla, PhD.
(5/2019, Main topic ) - News in the treatment of non-small cell lung cancer in the first half of 2023 in the world and new therapies in Slovakia
MUDr. Dominik Šafčák, PhD., MPH
(S2/2023, Review articles ) - State of the art and treatment perspectives of penile cancer
Doc. MUDr. Katarína Rejleková, PhD.
(3/2024, Main topic ) - Advanced urothelial carcinoma systemic treatment in the light of immunotherapy
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA
(3/2017, Review articles ) - Cemiplimab in the treatment of advanced cutaneous squamous cell carcinoma
MUDr. Radovan Barila, PhD.
(3/2021, Drugs & drug classes ) - Bratislavské onkologické dni LVI. ročník
Kolektív autorov
(S3/2019, Abstracts ) - Current treatment options for advanced cholangiocarcinoma
MUDr. Benjamin Špánik, MUDr. Tomáš Šálek, MUDr. Natália Pazderová, MUDr. Eva Zomborská, MUDr. Mgr. Zuzana Mináriková, PhD., MUDr. Ján Slopovský, MUDr. Štefan Pörsök, PhD., MPH
(5/2022, Main topic ) - The treatment of metastatic malignant melanoma
MUDr. Melinda Kráčalíková
(4/2024, Main topic ) - Use of nivolumab in solid tumours
MUDr. Katarína Bahnová
(4/2024, Review articles ) - Toxicity of immune checkpoint inhibitors in the elderly patients
MUDr. Jakub Tomko
(3/2025, Main topic ) - Hepatocellular carcinoma
MUDr. Tomáš Šálek
(6/2019, Main topic ) - News in systemic treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(6/2018, Review articles ) - Metastatic Merkel cell carcinoma and its treatment options
MUDr. Michaela Sojáková
(3/2023, Review articles )
- Rare skin tumours: Merkel cell carcinoma and rare tumours of melanocytic and epidermal origin – 2. part
MUDr. Zuzana Zelenayová
(4/2023, Review articles )